Dual antiplatelet therapy duration and mortality - Authors' reply

Lancet. 2015 May 30;385(9983):2149-50. doi: 10.1016/S0140-6736(15)61019-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiovascular Diseases / drug therapy*
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Purinergic P2Y Receptor Antagonists / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists